Legacy Advisors’s Clorox CLX Stock Holding History

Legacy Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,000	Closed	-$150K	–	175
2018 Q3	$150K	Buy	+1,000	New	+$142K	0.07%	155

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Legacy Advisors's CLX Position: Q4 2018 in Review

Legacy Advisors sold out of Clorox (CLX) in Q4 2018, closing a stake of 1,000 shares — an estimated $150K sold.

Legacy Advisors first reported a position in CLX in Q3 2018 and held it in 1 quarter. The position peaked at $150K in Q3 2018. 989 funds tracked by Wall St. Rank hold CLX as of Q4 2018.

Legacy Advisors reported no remaining Clorox position as of Q4 2018 after selling out during the quarter.
Legacy Advisors sold 1,000 Clorox shares in Q4 2018, an estimated $150K.
Legacy Advisors first reported a position in Clorox in Q3 2018 and held it in 1 quarter.
Legacy Advisors's Clorox position peaked at $150K in Q3 2018.
989 funds tracked by Wall St. Rank held Clorox as of Q4 2018.

Based on Legacy Advisors's 13F filing for Q4 2018, filed 14 Jan 2019.